Department of Surgery »  Faculty »  Emeritus Faculty »  Michael R. Harrison, M.D.

Michael R. Harrison, M.D.

Director Emeritus, Fetal Treatment Center
Division of Pediatric Surgery
Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology and Reproductive Sciences

Contact Information

  • 1961-65, Yale University, B.A.
  • 1965-69, Harvard Medical School, M.D., Medicine
  • 1969-71, Massachusetts General Hospital, Resident, Surgery
  • 1973-74, Massachusetts General Hospital, Senior Resident, Surgery
  • 1974-75, Massachusetts General Hospital, Chief Resident, Surgery
  • 1971-73, Laboratory of Immunology, National Institute of Allergy and Infectious Disease, Fellow, Allergy & Immunology (Peds)
  • 1975-76, Rikshospitalet, Fellow, Pediatric Surgery
  • 1976-78, Children's Hospital of Los Angeles, Fellow, Pediatric Surgery
  • American Board of Surgery, 1978, renewed 1988
  • American Board of Surgery, Special Competence in Pediatric Surgery, 1979, renewed 1989
  • American Board of Surgery, Surgical Critical Care, 1991
  • Fetal Treatment Center
  • Birth Defects
  • Congenital Diaphragmatic Hernia (CDH)
  • Fetal Surgery
  • Minimally Invasive Surgery
  • Pediatric Surgery
  • Developmental Biology
  • Hematopoietic Stem Cells
  • Pectus Excavatum Repair
  • World Health
  • Birth Defects
  • Minimally Invastive Surgery

Dr. Michael Harrison is Professor Emeritus of Surgery and Pediatrics and the Director Emeritus of the Fetal Treatment Center at UCSF. He graduated cum laude from Yale University and magna cum laude from Harvard Medical School. He completed his surgical training at the Massachusetts General Hospital in Boston and his pediatric surgery fellowship at Children's Hospital of Los Angeles. He is board certified in Surgery, Pediatric Surgery, and Critical Care.

Dr. Harrison and his surgery associates confine their surgical practice exclusively to children with special interest in fetal surgery, in repair of complex birth defects involving the chest, lung, abdomen, bowel, and bladder, and surgical care of children from birth through adolescence. Dr. Harrison and his associates, The Bay Area Pediatric Surgeons, do consultations and provide surgical care at Moffitt/Long Hospitals UCSF, California Pacific Medical Center, and Kaiser Permanente, San Francisco.

Dr. Harrison has a special interest in fetal surgery which he has pioneered with his colleagues at UCSF. For the past 18 years Dr. Harrison has studied the pathophysiology and natural history of a number of life-threatening fetal abnormalities including congenital diaphragmatic hernia, congenital cystic adenomatoid malformation of the lung, sacrococcygeal teratoma, fetal obstructive uropathy, and myelomeningocele. He has developed techniques for both in-utero open fetal surgery and endoscopic surgical repair (FETENDO Fetal Surgery)of many fetal abnormalities. In addition, Dr. Harrison's team has developed in-utero stem cell transplantation to treat immunodeficiencies, enzyme deficiencies, and hemoglobinopathies. Dr. Harrison leads the multidisciplinary UCSF Fetal Treatment Center Team that has developed an international reputation for treating complex birth defects before and after birth. (Referrals can be made to 1-800-RX-FETUS.)

Dr. Harrison, his wife Gretchen, and four children have lived in San Francisco for the past 20 years.

Most recent publications from a total of 419
  1. Swisher SL, Lin MC, Liao A, Leeflang EJ, Khan Y, Pavinatto FJ, Mann K, Naujokas A, Young D, Roy S, Harrison MR, Arias AC, Subramanian V, Maharbiz MM. Impedance sensing device enables early detection of pressure ulcers in vivo. Nat Commun. 2015; 6:6575. View in PubMed
  2. Harrison MR, Emamaullee JE, Besner GE. Profiles in surgical research: Michael R. Harrison, MD, FACS. Bull Am Coll Surg. 2015 Jan; 100(1):35-40. View in PubMed
  3. Li R, Beebe T, Jen N, Yu F, Takabe W, Harrison M, Cao H, Lee J, Yang H, Han P, Wang K, Shimizu H, Chen J, Lien CL, Chi NC, Hsiai TK. Shear stress-activated Wnt-angiopoietin-2 signaling recapitulates vascular repair in zebrafish embryos. Arterioscler Thromb Vasc Biol. 2014 Oct; 34(10):2268-75. View in PubMed
  4. Hirsch BR, Harrison MR, George DJ, Walker MS, Chen C, Korytowsky B, Stepanski E, Abernethy AP. Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice. Med Oncol. 2014 Sep; 31(9):156. View in PubMed
  5. Miniaturizing RFID for magnamosis. Conf Proc IEEE Eng Med Biol Soc. 2014 Aug; 2014:638-41. View in PubMed
  6. Hirsch BR, George DJ, Harrison MR. Treatment selection in metastatic renal cell carcinoma: more confusion or a path forward? Clin Adv Hematol Oncol. 2014 Mar; 12(3):163-71. View in PubMed
  7. Harrison MR, Armstrong AJ. Burden of disease matters when it comes to systemic therapy for prostate cancer. Eur Urol. 2015 Mar; 67(3):448-50. View in PubMed
  8. Harrison MR, Jones LW. Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: ready for prime time? Eur Urol. 2014 May; 65(5):873-4. View in PubMed
  9. Harrison MR, Hirsch BR, George DJ, Walker MS, Chen C, Korytowsky B, Stepanski E, Abernethy AP. Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic Registry. J Oncol Pract. 2014 Mar; 10(2):e63-72. View in PubMed
  10. Jiang H, Zhang J, Lan D. A low-frequency versatile wireless power transfer technology for biomedical implants. IEEE Trans Biomed Circuits Syst. 2013 Aug; 7(4):526-35. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Michael R. Harrison, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X